SEC FORM 4
$300,845.80
GeneDx Holdings Corp. (WGS)
Sale of 3,039 shares at $98.9950 per share.
Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →